# Toviaz Post Marketing Surveillance Study

> **NCT00879398** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 3000 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Toviaz treatment

## Key facts

- **NCT ID:** NCT00879398
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879398, "Toviaz Post Marketing Surveillance Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00879398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*